Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.66 |
| ▸ | HTT | P42858 | 4/20 | 0.66 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 10/20 | 0.65 |
| ▸ | MAPT | P10636 | 6/20 | 0.65 |
| ▸ | MEN1 | O00255 | 5/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.65 |
| ▸ | HPGD | P15428 | 4/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 8/20 | 0.61 |
| ▸ | ESRRG | P62508 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29664124 | 1.00 | LMNA (0.66) | LMNASMN1; SMN2HTTKCNH2NPC1 | |
| SCHEMBL8768783 | 0.86 | MEN1 (0.55) | LMNASMN1; SMN2HTTKCNH2NPC1 | |
| SCHEMBL10488407 | 0.84 | LMNA (0.79) | LMNASMN1; SMN2HTTKCNH2NPC1 | |
| SCHEMBL268855 | 0.83 | RAB9A (0.73) | LMNASMN1; SMN2HTTKCNH2NPC1 | |
| SCHEMBL450084 | 0.83 | RAB9A (0.85) | LMNASMN1; SMN2HTTKCNH2NPC1 | |
| Avobenzone SCHEMBL6129882 | 0.83 | LMNA (0.71) | LMNASMN1; SMN2HTTKCNH2NPC1 | |
| SCHEMBL8391939 | 0.83 | NPC1 (0.63) | LMNASMN1; SMN2HTTKCNH2NPC1 | |
| SCHEMBL7594159 | 0.82 | NPC1 (0.71) | LMNASMN1; SMN2HTTKCNH2NPC1 | |
| SCHEMBL23093687 | 0.82 | LMNA (0.63) | LMNASMN1; SMN2HTTKCNH2NPC1 | |
| SCHEMBL1603455 | 0.82 | NPC1 (0.75) | LMNASMN1; SMN2HTTKCNH2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023110777-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE | L'OREAL (FR) | 2023-06-22 | — | — | WO | claimed |
| CN-110831569-B | Photoprotective compositions | 欧莱雅 | 2022-10-21 | — | — | CN | claimed |
| US-20220226215-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | L'OREAL (FR) | 2022-07-21 | — | — | US | claimed |
| CN-114699328-A | Photoprotective compositions | 欧莱雅 | 2022-07-05 | — | — | CN | claimed |
| US-20200138684-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | L'OREAL (FR) | 2020-05-07 | — | — | US | claimed |
| EP-3644954-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | L'Oreal (FR) | 2020-05-06 | — | — | EP | claimed |
| CN-110831569-A | Photoprotective composition comprising a dibenzoylmethane derivative, a merocyanine compound and a compound capable of accepting the energy of the triplet excitation level of the dibenzoylmethane compound | 欧莱雅 | 2020-02-21 | — | — | CN | claimed |
| WO-2019002495-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | L'OREAL (FR) | 2019-01-03 | — | — | WO | claimed |
| US-4814162-A | SUNSCREENS | L'OREAL (FR) | 1989-03-21 | — | — | US | claimed |
| EP-3717075-B1 | A BI-PHASE SUN CARE COMPOSITION | OREAL (FR) | 2024-10-30 | — | — | EP | disclosed |
| CN-117597102-A | Sun protection W/O emulsion | 莱雅公司 | 2024-02-23 | — | — | CN | disclosed |
| WO-2023110777-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE | L'OREAL (FR) | 2023-06-22 | — | — | WO | disclosed |
| US-20230040911-A1 | Oil-In-Water-Type Emulsion Cosmetic | L V M H RECHERCHE (FR) | 2023-02-09 | — | — | US | disclosed |
| US-20230025603-A1 | SUN CARE COMPOSITION | L'OREAL (FR) | 2023-01-26 | — | — | US | disclosed |
| US-5523484-A | DI- OR TRI-CARBONYL SULFONAMIDO-PHENYL COMPOUNDS AS CHARGE CONTROL AGENTS | EASTMAN KODAK COMPANY (US) | 1996-06-04 | — | — | US | disclosed |
| EP-0659738-A1 | N-(Carbonyl, carbonimidoyl, carbonothioyl) sulfonamide charge control agents and toners and developers | EASTMAN KODAK COMPANY (US) | 1995-06-28 | — | — | EP | disclosed |
| US-5405727-A | Electrophotography | EASTMAN KODAK COMPANY (US) | 1995-04-11 | — | — | US | disclosed |
| US-5385800-A | A metal-free, colorless, heat resistant controllers | EASTMAN KODAK COMPANY (US) | 1995-01-31 | — | — | US | disclosed |
| US-4814162-A | SUNSCREENS | L'OREAL (FR) | 1989-03-21 | — | — | US | disclosed |
| US-4710584-A | Derivatives of 3-benzylidene camphor, process for their preparation and their use as protective agents against UV rays and as medicaments | L'OREAL (FR) | 1987-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200138684-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | DDT, ERCC5, ERCC1 | LMNA 2725/4885SMN1; SMN2 4778/4885HTT 777/4885 |
| US-20230040911-A1 | Oil-In-Water-Type Emulsion Cosmetic | CUTA, PHOSPHO1, LIPE | LMNA 874/4885SMN1; SMN2 4622/4885HTT 3102/4885 |
| US-20220226215-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | ERCC5, DDT, ERCC1 | LMNA 2955/4885SMN1; SMN2 4794/4885HTT 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.